EGFR and neoplasm: Although no significant correlation between the expressions of EGFR and CXCR4 was found in our study, we demonstrated for the first time that EGF/CXCR4 coexpression identified a subset of resected PDAC patients with more aggressive tumor characteristics and was associated with a significantly higher risk for both recurrence and death.